English

Choose language

Back

  • Deutsch

  • English

  • Español

  • Français

  • Polski

  • Русский

  • Українська


English

Two New IPO's: +33% and +41% Yield!

With five IPO's recommended through a single week, this may be the hottest time for the investors ever! While the market is gaining momentum after a two-month break, the companies with good potential are making their way to stock exchanges one after another. We already invited you to trade three IPO's this week: Warner Music Group, Pliant Therapeutics, and ZoomInfo Technogies. Here are two more: Legend Biotech, a new cancer treatment method developer, with a 41% potential, and Shift4 Payments, a leader in integrated payment processing, which may gain 33%.

You can apply to trade both IPO's before June 3, 19:00 pm.


Legend Biotech IPO

Legend Biotech is a part of GenScript Biotech, a US biopharma group listed in the Hong Kong Stock Exchange. This company is focused on developing cell-based therapy against myeloma, or blood plasma cell cancer. Johnson&Johnson invested $350M into Legend Biotech projects.

Legend Biotech is launching its IPO as LEGN in the NASDAQ on June 4, with the starting price between $18 and $20 per share.

IPO Size: $350M

IPO Cap: $2.458B

Potential Target Market: $50B

Freedom Finance Recommendation: Buy

With the commercialization likelihood and the associated risks taken into account, Legend Biotech is worth $3.641B, which is 41% more than the estimated IPO capitalization.

We are expecting a target price of $28.10 per share, with the growth potential of 41% (as of the IPO price high at $20).


Apply to Trade LEGN IPO


IPO Shift4 Payments, Inc.

Shift4 Payments is one of the largest credit card payment operators in the US. The solutions developed by this company are integrated into websites and apps to process credit, debit, or wireless card payments, as well as e-wallet payments. Shift4 Payments processes around 3.5B transactions for 200,000 companies, with the total amount of over $200B, yearly. Over 2019, the company grew by 30.50%.

Shift4 Payments is launching its IPO as FOUR in the NYSE on June 4, with the starting price between $19 and $21 per share.

IPO Size: $300M

IPO Cap: $1.608B

Potential Target Market: $98B by 2027

Freedom Finance Recommendation: Buy

With all risks taken into account, Shift4 Payments is worth $2.317B, which is 33% more than the estimated IPO capitalization.

We are expecting a target price of $28 per share, with the growth potential of 33% (as of the IPO price high at $21).


Apply to Trade FOUR IPO


How to Trade on an IPO

You can apply to trade both IPO's before June 3, 19:00 (UTC+2). In order to trade on an IPO, you need an investment account with Freedom Finance.

If you are already a Freedom Finance client, just log into your account to start trading.

If you don't have a Freedom Finance account yet, we recommend you opening it as soon as possible. Otherwise, you may miss it, as there are less than two days left before the IPO, while the account verification process after opening and funding it may take more than one business day.


*Investment in stocks and other financial instruments may result in loss of capital. Past investment results do not guarantee future returns. The forecasts are not reliable indicator of future performance.